Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Bergot, O. Sitbon, V. Cottin, A. Yaici, G. Prévot, L. Rottat, V. Gressin, M. Humbert, G. Simonneau (Caen, Clamart, Lyon, Toulouse, Paris, France). Current epoprostenol use in patients with severe pulmonary hypertension (PH): Data from the French PH registry. Eur Respir J 2011; 38: Suppl. 55, 2382

Member's Comments

No comment yet.

Related content which might interest you: Observational retrospective study on the treatment of pulmonary hypertension (PH) associated to pulmonary disease in patient with PH out of proportion Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 Clinical sildenafil use in Belgian patients with pulmonary arterial hypertension (PAH) Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Riociguat for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Real-life data from the EXPERT registry Source: International Congress 2015 – Pulmonary hypertension: new treatment insights Year: 2015 Idiopathic pulmonary arterial hypertension in the elderly: Data from the French registry Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011 Riociguat for the treatment of pulmonary hypertension: Safety data from the EXPERT registry Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 The French registry of pulmonary arterial hypertension in children: characteristics at diagnosis Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension Year: 2007 Epidemiology of pulmonary hypertension. Preliminary results of the Spanish pulmonary hypertension registry Source: Annual Congress 2009 - Pulmonary arterial hypertension Year: 2009 Long–term follow-up of patients on sildenafil from Croatian pulmonary hypertension registry Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 First international registry on chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD): Preliminary data of a longitudinal survey Source: International Congress 2014 – Clinical presentations Year: 2014 Issues related to the management and therapy of paediatric pulmonary hypertension Source: Eur Respir Rev 2010 19: 331-339 Year: 2010 Initial results of the UK audit of chronic thromboembolic pulmonary hypertension (CTEPH) Source: Eur Respir J 2007; 30: Suppl. 51, 486s Year: 2007 Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry Source: Eur Respir J, 55 (5) 1901747; 10.1183/13993003.01747-2019 Year: 2020 TOPP: the first international registry in pediatric pulmonary hypertension Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 Cambridge pulmonary hypertension outcomes review (CAMPHOR) utility assessment in pulmonary hypertension (PH) patients Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007 Identifying chronic thromboembolic pulmonary hypertension (CTEPH) through French national hospital database (PMSI) Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry Source: Eur Respir J, 52 (6) 1801687; 10.1183/13993003.01687-2018 Year: 2018 Responsiveness of cambridge pulmonary hypertension outcome review (CAMPHOR) scores and utility in pulmonary hypertension (PH) patients Source: Eur Respir J 2007; 30: Suppl. 51, 343s Year: 2007 Different response to pulmonay vasoactive therapy in pulmonary hypertension due to lung diseases (group III PH)  Report from a pneumology based PH center Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Riociguat for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH): Final data from a phase II long-term extension (LTE) study Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots Year: 2015